MONICKE MAGNON: Open Payments
NPI 1447768783 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,170 in 48 payments from 11 companies in 2025. Trend: 2023 $1,670 · 2024 $975 · 2025 $2,170
Food & beverage: $2,117Education: $53
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $600 |
| VERTEX PHARMACEUTICALS INCORPORATED | 13 | $362 |
| Novo Nordisk Inc | 3 | $336 |
| Inspire Medical Systems, Inc. | 14 | $208 |
| AERIN MEDICAL INC. | 3 | $198 |
| GENZYME CORPORATION | 4 | $150 |
| Stryker Corporation | 1 | $112 |
| Insulet Corporation | 1 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
Products named: FREESTYLE LIBRE 3, JOURNAVX, Ozempic, INSPIRE, DUPIXENT, VIVAER STYLUS, SCOPIS ENT, OMNIPOD.
Industry payments across TX — which companies pay providers there.
